Sfoglia per AUTORE
MARCONCINI R
Collezione AOU San Luigi di Orbassano

  

Items : 5

A randomized phase II trial of Captem or Folfiri as second-line therapy in neuroendocrine carcinomas. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2024 Sep;208:114129. doi: 10.1016/j.ejca.2024.114129. Epub 2024 May 25.
2024
AOU San Luigi di Orbassano

Bongiovanni A; Liverani C; Foca F; Bergamo F; Leo S; Pusceddu S; Gelsomino F; Brizzi MP; Di Meglio G; Spada F; Tamberi S; Lolli I; Cives M; Marconcini R; Pucci F; Berardi R; Antonuzzo L; Badalamenti G; Santini D; Recine F; Vanni S; Tebaldi M; Severi S; Rudnas B; Nanni O; Ranallo N; Crudi L; Calabrò L; Ibrahim T; et alii...

Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors. in JAMA network open / JAMA Netw Open. 2022 Feb 1;5(2):e220290. doi: 10.1001/jamanetworkopen.2022.0290.
2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Modica R; Andreasi V; Spada F; Severi S; Bracigliano A; Ambrosio MR; Zanata I; Puliafito I; Lamberti G; Cingarlini S; Rocca PA; Pignata SA; Rinzivillo M; Persano I; Versari A; Bongiovanni A; Lastoria S; Maccauro M; Seregni E; Di Maio M; Porcu L; Giacomelli L; Ricci C; Corti F; Perfetti V; Cirillo F; Grimaldi F; Cives M; Bajetta E; et alii...

Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: A real-world study. in Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] / Pancreatology. 2018 Mar;18(2):198-203. doi: 10.1016/j.pan.2018.01.005. Epub 2018 Jan 12.
2018
AOU San Luigi di Orbassano

Rinzivillo M; Fazio N; Pusceddu S; Spallanzani A; Ibrahim T; Campana D; Marconcini R; Partelli S; Badalamenti G; Brizzi MP; Catena L; Schinzari G; Carnaghi C; Berardi R; Faggiano A; Antonuzzo L; Spada F; Gritti S; Femia D; Gelsomino F; Bongiovanni A; Ricci S; Brighi N; Falconi M; Delle Fave G; Panzuto F;

A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors. in Endocrine-related cancer / Endocr Relat Cancer. 2018 Jun;25(6):607-618. doi: 10.1530/ERC-17-0489. Epub 2018 Mar 20.
2018
AOU San Luigi di Orbassano

Pusceddu S; Barretta F; Trama A; Botta L; Milione M; Buzzoni R; De Braud F; Mazzaferro V; Pastorino U; Seregni E; Mariani L; Gatta G; Di Bartolomeo M; Femia D; Prinzi N; Coppa J; Panzuto F; Antonuzzo L; Bajetta E; Brizzi MP; Campana D; Catena L; Comber H; Dwane F; Fazio N; Faggiano A; Giuffrida D; Henau K; Ibrahim T; et alii...

Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues. in Gastroenterology / Gastroenterology. 2018 Aug;155(2):479-489.e7. doi: 10.1053/j.gastro.2018.04.010. Epub 2018 Apr 13.
2018
AO Cuneo
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Mazzaferro V; Buzzoni R; Delle Fave G; Giacomelli L; Milione M; Lo Russo G; Concas L; Femia D; Prinzi N; Garattini SK; Bajetta E; Tafuto S; Di Costanzo F; Torniai M; Zaniboni A; Ortolani S; Puliafito I; Panzuto F; Colao A; Brighi N; La Salvia A; Cavalcoli F; Bongiovanni A; Fazio N; Ricci S; Duro M; Davì MV; Cauchi C; Carnaghi C; et alii...